Merriman Curhan Ford bolster biotech platform
by Richard Kilner
Story link: Merriman Curhan Ford bolster biotech platform
Edward H. Nash has been hired by financial services firm Merriman Curhan Ford to serve as a senior biotechnology equity research analyst and MD.
Nash brings with him over a decade of experience as a biotechnology analyst, and is to be based in the firm’s New York office.
He leaves behind Stifel, Nicolaus & Co, where he was also a senior biotechnology analyst, to join Merriman Curhan Ford.
During his career he has held similar positions with Rodman & Renshaw, Commerce Capital Markets, Ladenburg Thalmann & Co. and Lazard Freres & Co.
Jon Merriman, the firm’s CEO, has paid tribute to Nash’s high level of experience, describing his background as a great fit for the company’s platform and expressing his pleasure at the appointment.
Add to Bookmarks:
Related stories to: Merriman Curhan Ford bolster biotech platform
Merriman Curhan Ford hires two healthcare investment bankers ... Deutsche Bank’s ETF platform raises 15bn euros ...»
No comments yet.Leave a comment
Previous: « Jefferies appoints two investment banking chiefs
Next: Baird begins investment banking in Asia »
Visited 495 times, 4 so far today